This may be mediated via RRAS binding and activating phosphatidylinositol-3inase (PI3K), because a PI3K inhibitor (LY294002) inhibited RRAS-induced RAC1 activation [25]
This pathway may possibly be regulated by activation/inactivation of RRAS, the system of which...